Ipilimumab

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

Advertisement - Members don't see this ad
hm, interesting. I did not know CTLA-4 inhibitors were this close to becoming used in clinical settings. I could definitely see this drug causing problems with overreactive t cells, especially in patients who may be susceptible to auto immune disease.